Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.45 |
| ▸ | RAB9A | P51151 | 5/20 | 0.45 |
| ▸ | NPC1 | O15118 | 4/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19484074 | 0.97 | THRB (0.51) | THRBMAPK1ALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL19484082 | 0.91 | THRB (0.52) | THRBMAPK1ALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL19484111 | 0.90 | THRB (0.51) | THRBMAPK1ALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL19484077 | 0.88 | THRB (0.50) | THRBMAPK1ALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL19484076 | 0.88 | THRB (0.50) | THRBMAPK1ALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL19484067 | 0.87 | THRB (0.53) | THRBMAPK1ALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL19484075 | 0.85 | MAPK1 (0.59) | THRBMAPK1ALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL19484085 | 0.85 | THRB (0.49) | THRBMAPK1ALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL19484216 | 0.82 | NPC1 (0.46) | MAPK1ALDH1A1SMN1; SMN2RAB9ANPC1 | |
| SCHEMBL19484079 | 0.82 | THRB (0.54) | THRBMAPK1ALDH1A1SMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170295789-A1 | AMIDE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170295789-A1 | AMIDE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL | OPRM1, TRPA1, L3MBTL3 | THRB 2489/4885MAPK1 2014/4885ALDH1A1 1868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.